The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma

OBJECTIVE: Limited studies have reported the impact of drug-eluting bead transarterial chemoembolization (DEB-TACE) on hepatic fibrosis in hepatocellular carcinoma (HCC). This study evaluated multiple hepatic fibrosis indicators, aiming to comprehensively compare the influence of DEB-TACE and conven...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hao, Liang, Chao, Kuang, Donglin, Huang, Guohao, Zhang, Mengfan, Chen, Pengfei, Zheng, Qingzhu, Xu, Wenze, Ren, Jianzhuang, Han, Xinwei, Duan, Xuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928450/
https://www.ncbi.nlm.nih.gov/pubmed/36751709
http://dx.doi.org/10.1080/15384047.2023.2166335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928450/
https://www.ncbi.nlm.nih.gov/pubmed/36751709
http://dx.doi.org/10.1080/15384047.2023.2166335

Ejemplares similares